Nuclear medicine production at ANSTO
Media statement from ANSTO.
Showing 921 - 940 of 1508 results
Media statement from ANSTO.
Dr Peter Kappen manages the Spectroscopy Group at the Australian Synchrotron.
Mr Michael Quigley is an experienced director, senior business executive and former engineer. He has extensive corporate, financial and governance experience across the public and private sectors.
Scientists from Monash, ANSTo and China have developed an ultra-thin membrane that could separate harmful ions from water or capture gases.
New technology is being developed in Sydney to recycle used Personal Protective Equipment (PPE) and turn it into raw materials for 3D printing.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
Health researchers have developed a new method for producing PET radiotracers.
Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.
Role at ANSTO
Two ANSTO environmental scientists are part of a large team led by the Australian National University (ANU), who have received an Australian Research Council Discovery Project grant to investigate how environmental change and human activities since industrialisation have impacted the transport and deposition of toxic metals on the south coast of Australia, Tasmania, and remote Southern Ocean islands.
John is currently one of two co-Directors of the Health Research and Technology Group at ANSTO.
He is Director of the ANSTO node of the NCRIS National Imaging Facility and is a member of the NIF Scientific Advisory Committee.